APCDD1L | Adenomatosis polyposis coli down-regulated 1-like | Predicted intracellular proteins Predicted membrane proteins
| ![](/images/67015/154622_B_1_1_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/67015/154619_A_2_4_rna_selected_60x60.jpg) | Tissue enhanced |
AQP5 | Aquaporin 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/65008/145373_A_3_5_selected_60x60.jpg) | ![](/images/65008/145411_B_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
ATP13A5 | ATPase type 13A5 | Predicted membrane proteins
| ![](/images/31771/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/31771/72926_A_2_5_rna_selected_60x60.jpg) | Tissue enhanced |
ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | Enzymes Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5606/18338_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
ATP6V1B1 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 | Disease related genes Predicted intracellular proteins
| | ![](/images/31847/1381_F5_4_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/31847/111072_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
ATP6V1C2 | ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2 | Predicted intracellular proteins Transporters
| ![](/images/34734/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/34734/75429_A_3_1_rna_selected_60x60.jpg) | Tissue enhanced |
BARX2 | BARX homeobox 2 | Predicted intracellular proteins Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/33311/67670_A_3_8_rna_selected_60x60.jpg) | Tissue enhanced |
BPIFA1 | BPI fold containing family A, member 1 | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25669/59312_B_2_4_rna_selected_60x60.jpg) | Tissue enhanced |
BPIFB1 | BPI fold containing family B, member 1 | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/24256/55104_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
BSPRY | B-box and SPRY domain containing | Predicted intracellular proteins
| ![](/images/42889/ihc_selected_60x60.jpg) | ![](/images/42889/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/42889/95847_A_6_3_rna_selected_60x60.jpg) | Tissue enhanced |
C17orf107 | Chromosome 17 open reading frame 107 | Predicted intracellular proteins
| ![](/images/69713/ihc_selected_60x60.jpg) | ![](/images/69713/1446_B10_6_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/69713/153824_B_3_2_rna_selected_60x60.jpg) | Tissue enhanced |
C1orf64 | Chromosome 1 open reading frame 64 | Predicted intracellular proteins
| ![](/images/26676/ihc_selected_60x60.jpg) | ![](/images/26676/609_E8_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/26676/55166_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
C5orf38 | Chromosome 5 open reading frame 38 | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CCDC129 | Coiled-coil domain containing 129 | Predicted intracellular proteins Predicted secreted proteins
| ![](/images/24103/ihc_selected_60x60.jpg) | ![](/images/24103/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/24103/51990_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
CCDC160 | Coiled-coil domain containing 160 | Predicted intracellular proteins
| ![](/images/44684/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44684/98473_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
CLDN10 | Claudin 10 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42348/146593_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
CLPSL2 | Colipase-like 2 | Predicted secreted proteins
| ![](/images/51655/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51655/120632_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
COL28A1 | Collagen, type XXVIII, alpha 1 | Predicted intracellular proteins Predicted secreted proteins
| ![](/images/60468/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60468/136363_B_9_6_rna_selected_60x60.jpg) | Tissue enhanced |
CRACR2A | Calcium release activated channel regulator 2A | Predicted intracellular proteins
| ![](/images/38686/157400_B_2_1_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/38686/157397_A_2_3_rna_selected_60x60.jpg) | Tissue enhanced |
CRACR2B | Calcium release activated channel regulator 2B | Predicted intracellular proteins
| ![](/images/46217/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46217/102062_B_3_1_rna_selected_60x60.jpg) | Tissue enhanced |
CTB-102L5.4 | | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CTD-2313N18.7 | Beta-defensin 131-like precursor | Predicted secreted proteins
| ![](/images/52257/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/52257/119781_B_3_7_rna_selected_60x60.jpg) | Tissue enhanced |
DTNB | Dystrobrevin, beta | Plasma proteins Predicted intracellular proteins
| ![](/images/61357/ihc_selected_60x60.jpg) | ![](/images/61357/1307_A6_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/61357/138458_B_5_1_rna_selected_60x60.jpg) | Tissue enhanced |
EDN3 | Endothelin 3 | Disease related genes Predicted secreted proteins
| ![](/images/57987/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/57987/132485_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
ETV1 | Ets variant 1 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
FAM196B | Family with sequence similarity 196, member B | Predicted intracellular proteins
| ![](/images/47227/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47227/112685_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
FAM3D | Family with sequence similarity 3, member D | Predicted intracellular proteins Predicted membrane proteins
| ![](/images/13844/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/13844/ihc_cell_selected_60x60.jpg) | ![](/images/13844/32230_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
FXYD2 | FXYD domain containing ion transport regulator 2 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/68838/154055_A_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
FXYD6-FXYD2 | FXYD6-FXYD2 readthrough | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
HSD11B2 | Hydroxysteroid (11-beta) dehydrogenase 2 | Disease related genes Predicted membrane proteins
| | ![](/images/56385/1395_G5_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/32443/80277_B_1_1_rna_selected_60x60.jpg) | Tissue enhanced |
IL19 | Interleukin 19 | Predicted membrane proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
IRX1 | Iroquois homeobox 1 | Plasma proteins Predicted intracellular proteins Transcription factors
| ![](/images/43160/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/43160/93427_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
IRX2 | Iroquois homeobox 2 | Predicted intracellular proteins Transcription factors
| ![](/images/54669/ihc_selected_60x60.jpg) | ![](/images/50895/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/54669/125409_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
IRX5 | Iroquois homeobox 5 | Disease related genes Predicted intracellular proteins Transcription factors
| ![](/images/47130/ihc_selected_60x60.jpg) | ![](/images/47130/1314_A6_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/47130/106777_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
ISL2 | ISL LIM homeobox 2 | Predicted intracellular proteins Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
KCNN4 | Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters Voltage-gated ion channels
| ![](/images/59622/ihc_selected_60x60.jpg) | ![](/images/53841/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/53841/133784_B_2_4_rna_selected_60x60.jpg) | Tissue enhanced |
KIAA1324 | KIAA1324 | Predicted membrane proteins Predicted secreted proteins
| ![](/images/29869/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29869/89488_B_8_8_rna_selected_60x60.jpg) | Tissue enhanced |
KLK15 | Kallikrein-related peptidase 15 | Cancer-related genes Enzymes Predicted intracellular proteins Predicted secreted proteins
| ![](/images/19802/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/19802/47764_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
LHFPL1 | Lipoma HMGIC fusion partner-like 1 | Predicted membrane proteins
| ![](/images/3029/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3029/9023_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
LRRTM1 | Leucine rich repeat transmembrane neuronal 1 | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62660/144003_B_8_8_rna_selected_60x60.jpg) | Tissue enhanced |
MFI2 | Antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 | CD markers Plasma proteins Predicted secreted proteins
| ![](/images/4880/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/4880/ihc_cell_selected_60x60.jpg) | ![](/images/4880/14048_B_1_3_rna_selected_60x60.jpg) | Tissue enhanced |
NEURL3 | Neuralized E3 ubiquitin protein ligase 3 | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
PAX9 | Paired box 9 | Disease related genes Predicted intracellular proteins Transcription factors
| ![](/images/38462/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/38462/79558_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
PLEKHS1 | Pleckstrin homology domain containing, family S member 1 | Predicted intracellular proteins
| ![](/images/37583/ihc_selected_60x60.jpg) | ![](/images/37583/1396_F12_9_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/37583/74545_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
PLIN5 | Perilipin 5 | Predicted intracellular proteins Predicted membrane proteins
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
PPP1R1B | Protein phosphatase 1, regulatory (inhibitor) subunit 1B | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/61142/136291_B_5_2_rna_selected_60x60.jpg) | Tissue enhanced |
PTCH2 | Patched 2 | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins
| ![](/images/46839/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46839/109074_A_3_7_rna_selected_60x60.jpg) | Tissue enhanced |
RASAL1 | RAS protein activator like 1 (GAP1 like) | Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | ![](/images/41650/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/41650/92950_A_6_5_rna_selected_60x60.jpg) | Tissue enhanced |
RNASE13 | Ribonuclease, RNase A family, 13 (non-active) | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
SCGB1C1 | Secretoglobin, family 1C, member 1 | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |